FLORENCE, Italy, Sept. 1 (UPI) -- A daily capsule of omega-3 fish body oil can reduce mortality and admission to the hospital in patients with heart failure, Italian researchers said.
Luigi Tavazzi and Gianni Tognoni of the ANMCO Research Centre in Florence, Italy, and Mario Negri Institute in Milan, Italy, and colleagues said the randomized controlled trial involved 357 cardiology sites in Italy.
Almost 3,500 patients with chronic heart failure received omega-3 in a capsule once daily, while the same number received a placebo.
In the group that received the omega 3 -- 955 patients, or 27 percent died, compared with 1,014, or 29 percent in the placebo group -- meaning a relative risk reduction of 9 percent in the fish body group, Health Day News reported.
The study, published online in the journal The Lancet, said the study shows the long-term administration of 1 g per day omega was effective in reducing both all-cause mortality and admissions to hospital for cardiovascular reasons.
